Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)
HKD 0.28
(0.0%)
HKD 0.28
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 397.99 Million | 449.67 Million | 476.38 Million | 369.35 Million | 358.75 Million | 351.89 Million |
| Cost of Revenue | 376.63 Million | 433.28 Million | 430.77 Million | 328.96 Million | 323.75 Million | 350.19 Million |
| Gross Profit | 21.36 Million | 16.39 Million | 45.6 Million | 40.39 Million | 34.99 Million | 1.7 Million |
| Operating Expenses | 21.36 Million | 38.51 Million | 51.75 Million | 45.26 Million | 55.6 Million | 64.54 Million |
| Selling, General and Administrative Expenses | 29.9 Million | 37.48 Million | 48.75 Million | 40.33 Million | 46.16 Million | 53.92 Million |
| Research and Development Expenses | 1.31 Million | 1.13 Million | 3.49 Million | 5.51 Million | 8.29 Million | 11.66 Million |
| Other Expenses | - | -114.44 Thousand | -497.4 Thousand | -581.74 Thousand | 1.13 Million | 945.87 Thousand |
| Cost and Expenses | 407.83 Million | 471.79 Million | 482.53 Million | 374.23 Million | 379.36 Million | 414.74 Million |
| Operating Income | -9.83 Million | -20.8 Million | -4.44 Million | -21.74 Million | -27.93 Million | -59.54 Million |
| Interest Expense | 5.17 Million | 6.4 Million | 5.46 Million | 1.63 Million | 4.63 Million | 2.76 Million |
| Income Tax Expense | -1.04 Million | 150.7 Thousand | -54.7 Thousand | 362.76 Thousand | -5136.00 | 158.68 Thousand |
| Earnings before Tax | -12.01 Million | -26.49 Million | -44.83 Million | -50 Million | -88.81 Million | -300.47 Million |
| Net Income | -20.15 Million | -26.64 Million | -44.78 Million | -50.36 Million | -88.81 Million | -177.67 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 | -0.10 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | -0.03 | -0.05 | -0.10 |
| Weighted Average Shares Outstanding | 2.62 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.85 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.85 Billion |
| Gross Margin | 0.05 | 0.04 | 0.10 | 0.11 | 0.10 | 0.00 |
| EBIT Margin | 0.01 | -0.01 | 0.01 | -0.04 | -0.04 | -0.10 |
| Profit Margin | -0.05 | -0.06 | -0.09 | -0.14 | -0.25 | -0.50 |
| EBITDA | 4.79 Million | -2.26 Million | -29.85 Million | -14.64 Million | -13.32 Million | -35.48 Million |
| Earnings Before Tax Margin | -0.02 | -0.05 | -0.01 | -0.06 | -0.08 | -0.17 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 105.78 Million | 105.78 Million | 92.76 Million | 397.99 Million | 119.31 Million | 99.49 Million |
| Cost of Revenue | 99.72 Million | 99.72 Million | 82.9 Million | 376.63 Million | 114.66 Million | 95.69 Million |
| Gross Profit | 6.05 Million | 6.05 Million | 9.86 Million | 21.36 Million | 4.65 Million | 3.79 Million |
| Operating Expenses | 7.8 Million | 7.8 Million | 2.7 Million | 31.2 Million | 9.44 Million | 9.15 Million |
| Selling, General and Administrative Expenses | 7.8 Million | 7.8 Million | 22.94 Million | - | 1.67 Million | 2.24 Million |
| Research and Development Expenses | - | - | -20.22 Million | - | 7.76 Million | 6.9 Million |
| Other Expenses | - | - | 151.58 Thousand | -315.98 Thousand | -51.8 Thousand | -335.67 Thousand |
| Cost and Expenses | 107.53 Million | 107.53 Million | 85.6 Million | 407.83 Million | 124.11 Million | 104.85 Million |
| Operating Income | -1.74 Million | -1.74 Million | -2.33 Million | -19.33 Million | -4.84 Million | -5.69 Million |
| Interest Expense | - | - | 2.63 Million | 5.17 Million | 1.01 Million | 739.91 Thousand |
| Income Tax Expense | -700.91 Thousand | -700.91 Thousand | -1 Million | -1.04 Million | 179.39 Thousand | -42.11 Thousand |
| Earnings before Tax | -2.76 Million | -2.76 Million | 7.99 Million | -12.01 Million | -5.86 Million | -6.43 Million |
| Net Income | -2.06 Million | -2.06 Million | -2.86 Million | -20.15 Million | -6.04 Million | -5.37 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion | 1.89 Billion |
| Gross Margin | 0.06 | 0.06 | 0.11 | 0.05 | 0.04 | 0.04 |
| EBIT Margin | 0.00 | 0.00 | 0.08 | - | -0.04 | -0.06 |
| Profit Margin | -0.02 | -0.02 | -0.03 | -0.05 | -0.05 | -0.05 |
| EBITDA | 300.66 Thousand | 300.66 Thousand | 7.56 Million | - | -4.84 Million | -5.69 Million |
| Earnings Before Tax Margin | -0.02 | -0.02 | -0.03 | -0.05 | -0.04 | -0.06 |
CBG
OASPW
6637
MTE
EQPA3
VLYPP